The FDA approved Amgen and Wyeth Pharmaceuticals drug, Enbrel (etanercept), to inhibit the progression of structural damage in patients with active psoriatic arthritis and reduce its signs and symptoms.
Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Derm In The News: September 24-30
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis
Evaluating Efficacy of Trifarotene in Latin American Patients With Acne
2 Clarke Drive Cranbury, NJ 08512